377 related articles for article (PubMed ID: 21715211)
1. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
[TBL] [Abstract][Full Text] [Related]
3. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
[TBL] [Abstract][Full Text] [Related]
4. Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function.
Yajnik CS; Kantikar V; Pande A; Deslypere JP; Dupin J; Calvet JH; Bauduceau B
Diabetes Metab; 2013 Apr; 39(2):126-31. PubMed ID: 23159130
[TBL] [Abstract][Full Text] [Related]
5. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
[TBL] [Abstract][Full Text] [Related]
6. Sudomotor dysfunction is associated with foot ulceration in diabetes.
Tentolouris N; Marinou K; Kokotis P; Karanti A; Diakoumopoulou E; Katsilambros N
Diabet Med; 2009 Mar; 26(3):302-5. PubMed ID: 19317826
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
Papanas N; Papatheodorou K; Christakidis D; Papazoglou D; Giassakis G; Piperidou H; Monastiriotis C; Maltezos E
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):195-8. PubMed ID: 15891953
[TBL] [Abstract][Full Text] [Related]
8. Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic.
Calvet JH; Dupin J; Winiecki H; Schwarz PE
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):80-3. PubMed ID: 23073917
[TBL] [Abstract][Full Text] [Related]
9. Vibration perception threshold and the law of mobility in diabetic mellitus patients.
Manivannan M; Periyasamy R; Narayanamurthy VB
Prim Care Diabetes; 2009 Feb; 3(1):17-21. PubMed ID: 19071079
[TBL] [Abstract][Full Text] [Related]
10. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical examination, current and vibratory perception threshold in diabetic polyneuropathy.
Tack CJ; Netten PM; Scheepers MH; Meijer JW; Smits P; Lutterman J
Neth J Med; 1994 Feb; 44(2):41-9. PubMed ID: 8208323
[TBL] [Abstract][Full Text] [Related]
12. [Non-invasive diagnosis of angiopathies and neuropathies in screening for the diabetic foot syndrome].
Jirkovská A; Wosková V; Bartos V; Skibová J
Vnitr Lek; 1998 May; 44(5):269-73. PubMed ID: 9820070
[TBL] [Abstract][Full Text] [Related]
13. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet.
Sun PC; Lin HD; Jao SH; Chan RC; Kao MJ; Cheng CK
Diabet Med; 2008 Apr; 25(4):413-8. PubMed ID: 18341593
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of sudomotor dysfunction in patients with type 2 diabetes and peripheral neuropathy.
Shivaprasad C; Amit G; Anish K; Rakesh B; Anupam B; Aiswarya Y
Diabetes Res Clin Pract; 2018 May; 139():188-194. PubMed ID: 29524484
[TBL] [Abstract][Full Text] [Related]
16. Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study].
Ghosal S; Stephens J; Mukherjee A
Diabetes Metab Syndr; 2012; 6(2):85-9. PubMed ID: 23153975
[TBL] [Abstract][Full Text] [Related]
17. A new simple method for assessing sudomotor function: relevance in type 2 diabetes.
Mayaudon H; Miloche PO; Bauduceau B
Diabetes Metab; 2010 Dec; 36(6 Pt 1):450-4. PubMed ID: 20739207
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of vibratory threshold in the diagnosis of diabetic neuropathy].
Ribera RL; Valls J; González-Clemente JM; Vidal J; Manzanares JM; Esmatjes E
Rev Clin Esp; 1994 Oct; 194(10):901-5. PubMed ID: 7800871
[TBL] [Abstract][Full Text] [Related]
19. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
Coppini DV; Wellmer A; Weng C; Young PJ; Anand P; Sönksen PH
J Clin Neurosci; 2001 Nov; 8(6):520-4. PubMed ID: 11683597
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sudomotor function in adult patients with long‑lasting type 1 diabetes.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Pol Arch Intern Med; 2017 Jan; 127(1):16-24. PubMed ID: 28075427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
